CD8A and COVID-19: Thus, we have investigated whether in vitro stimulation of PBMCs from vaccinated individuals with a pool of peptides derived from the Spike protein resulted in activation of specific CD4+ and CD8+ T lymphocytes, as it was described in COVID-19 patients (17).